SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Medicamen Biotech informs about board meeting

23 Jun 2020 Evaluate

Medicamen Biotech has informed that a Meeting of the Board of Directors of the Company is scheduled to be held on June 30, 2020, to consider and approve the Audited Financial Results of the Company (Standalone and Consolidated) for the quarter/ year ended on March 31, 2020; to consider the recommendation of Final Dividend for the FY 2019-20 on the Equity Shares of the Company, subject to approval of shareholders in the ensuing Annual General Meeting; to appoint SPB & Co, Cost Accountants, as the Cost Auditor of the company for the financial year 2020-21; to appoint Cheena & Associates, as the Internal Auditor of the company for the financial year 2020-21; to appoint AMJ & Associates, as the Secretarial Auditor of the company for the financial year 2020-21; and any other business with the permission of the chair. In this connection, to Company’s letter dated March 31, 2020, wherein it was informed that pursuant to the Company’s Code of Conduct framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and amendments made there under, the trading window for dealing in the shares of the Company is closed for all designated persons of the Company from the April 01, 2020 and will open 48 hours after the said Financial Results are declared to BSE.

The above information is a part of company’s filings submitted to BSE.

Medicamen Biotech Share Price

225.85 -1.80 (-0.79%)
22-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1863.45
Dr. Reddys Lab 1291.05
Cipla 1415.30
Zydus Lifesciences 1084.35
Lupin 2339.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: